Certara

Gold Sponsor

Transforming drug discovery and development for good

Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries.

Certara acquired Chemaxon in 2024 to close gaps in the design-make-test-analyze cycle, bring promising leads into biosimulation, and speed up the launch of new medicines. Together, we help you innovate with confidence by turning your discovery process into a competitive advantage.

We will present our cheminformatics software solutions for chemical drawing, molecule design, data analysis, and compound data management alongside our latest AI developments.

Learn more at: https://www.certara.com/

website